Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Umeå University
- Baylor College of Medicine
- University of Maryland, Baltimore
- University of Washington
- Yale University
- Nencki Institute of Experimental Biology
- Wageningen University & Research
- Heidelberg University
- Pennsylvania State University
- St Jude Children's Research Hospital
- University of Miami
- University of Minnesota
- University of North Carolina at Chapel Hill
- University of Oxford
- Wayne State University
- Duke University
- Ghent University
- Helmholtz Association of German Research Centres
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- Human Technopole
- Josep Carreras Leukaemia Research Institute (IJC)
- KU LEUVEN
- King's College London
- Lehigh University
- Massachusetts Institute of Technology
- Max Planck Institute of Molecular Cell Biology and Genetics, Dresden
- Northeastern University
- Oak Ridge National Laboratory
- Research Center for Molecular Medicine (CeMM), ÖAW
- Rutgers University
- Stanford University
- Stowers Institute for Medical Research
- Texas A&M AgriLife
- Texas A&M University
- The Francis Crick Institute
- The International Institute of Molecular Mechanisms and Machines Polish Academy of Sciences
- The Ohio State University
- The University of North Carolina at Chapel Hill
- The University of South Dakota
- The Wistar Institute
- UNIVERSITY OF HELSINKI
- UNIVERSITY OF VIENNA
- University Hospital Magdeburg
- University of Colorado
- University of Dundee
- University of Florida
- University of Kentucky
- University of Southern Denmark (SDU)
- University of York
- 39 more »
- « less
-
Field
-
function. We utilize a variety of approaches including biochemical, proteomic, genomic, genome editing, and mouse modeling to study these questions. Here are representative recent publications from the lab
-
using Cre-Lox and gene therapy approaches to editing of MP in vivo. The gene therapy approaches are in pre-clinical development as novel therapies for humans with hypertension and heart failure
-
the laboratory of Dr. Steven Fisher in the Division of Cardiology at the University of Maryland-Baltimore as of April 1, 2019. The federally funded project examines vascular smooth muscle gene expression and
-
pluripotent stem cells (hiPSCs). Primary responsibility is to utilize the CRISPR/Cas9 genomic engineering technology to examine the impact of genomic ablation of the candidate target genes on iPSC-CM and animal
-
the laboratory of Dr. Steven Fisher in the Division of Cardiology at the University of Maryland-Baltimore as of October 1, 2020. The federally funded project examines vascular smooth muscle gene expression and
-
genomic ablation of the candidate target genes on iPSC-CM and animal models. Qualifications Applicants are required to have a Ph.D. or M.D. and expertise in techniques of cell and molecular biology